(Q41229313)

28 September 2017

1 reference

title

Steroid-resistant asthma: evaluation and management (English)

1 reference

28 September 2017

Nimmagadda SR

1

1 reference

28 September 2017

Spahn JD

series ordinal

2

1 reference

28 September 2017

Leung DY

series ordinal

3

1 reference

28 September 2017

Szefler SJ

series ordinal

4

1 reference

28 September 2017

publication date

1 November 1996

1 reference

Annals of Allergy, Asthma & Immunology

28 September 2017

published in

1 reference

28 September 2017

volume

77

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

345-55; quiz 355-6

1 reference

Steroid Resistance in Bronchial Asthma

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Steroid-resistant asthma: immunologic and pharmacologic features

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

The structure and function of steroid receptor proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Steroid receptor regulated transcription of specific genes and gene networks

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Function and activation of NF-kappa B in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Anti-inflammatory drugs in the treatment of allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Lipocortin-1: cellular mechanisms and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Effect of corticosteroid treatment on interleukin-1 and tumour necrosis factor secretion by monocytes from subjects with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Reduction of bronchial hyperreactivity during prolonged allergen avoidance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Investigating severe and fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Measuring adherence to asthma medication regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Psychologic side effects of therapy with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Coexistence of glucocorticoid receptor and pharmacokinetic abnormalities: factors that contribute to a poor response to treatment with glucocorticoids in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Alternative therapy in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Monitoring glucocorticoid therapy: a pharmacokinetic approach

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Measuring the response to glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Cyclosporin for steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Trial of cyclosporin in corticosteroid-dependent chronic severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Efficacy of low-dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Methotrexate in bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

The effect of methotrexate and hydroxyurea on neutrophil chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

The effects of methotrexate on the production and activity of interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Long-term methotrexate treatment in corticosteroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Methotrexate in the treatment of steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Comparison of methotrexate 30 mg per week with placebo in chronic steroid-dependent asthma: a 12-week double-blind, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

The role of methotrexate in the management of steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Possible mechanisms of intravenous immunoglobulin treatment in childhood idiopathic thrombocytopenic purpura (ITP).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

Chrysotherapy in the treatment of corticosteroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

An open study of auranofin in the treatment of steroid-dependent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963332-7

7 January 2021

10.1016/S1081-1206(10)63332-7

Identifiers

DOI

1 reference

28 September 2017

1 reference